Medicamen Biotech Ltd (MEDICAMEQ) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 770569,
    "name": "Medicamen Biotec",
    "stock_name": "Medicamen Biotec",
    "full_name": "Medicamen Biotech Ltd",
    "name_url": "stocks-analysis/medicamen-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "222.30",
    "chg": -2.15,
    "chgp": "-0.96%",
    "dir": -1,
    "prev_price": "224.45",
    "mcapval": "301.50 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531146,
    "symbol": "MEDICAMEQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE646B01010",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "24.3 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/medicamen-biotec-770569-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Medicamen Biotech Ltd Valuation Shifts Amidst Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-amidst-sector-challenges-3984619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicamenBiotec_valuationdot_3984619.png",
        "date": "2026-05-11 08:01:36",
        "description": "Medicamen Biotech Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting changing market perceptions and relative peer positioning. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the company’s valuation metrics reveal a complex picture of price attractiveness amid sector volatility and competitive pressures."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3975776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicamenBiotec_mojoScore_3975776.png",
        "date": "2026-05-05 10:10:17",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3960643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3960643.png",
        "date": "2026-04-24 10:10:31",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Medicamen Biotech Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-signal-changing-market-sentiment-3958294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_valuationdot_3958294.png",
        "date": "2026-04-23 08:00:58",
        "description": "Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite a recent uptick in its share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside subdued returns on capital, have raised concerns among investors and analysts alike."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3944618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3944618.png",
        "date": "2026-04-13 10:10:32",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 13 April 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3930156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3930156.png",
        "date": "2026-04-02 10:10:29",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "770569",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/medicamen-biotech-770569"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-May-2026",
      "details": "Announcement under Regulation 30 (LODR) - Newspaper Publication for BM held on 27.05.2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances - Regulation 32 (1) And (3) - Statament Of Deviation & Variation Report - March 2026",
      "datetime": "28-May-2026",
      "details": "Statement of Deviation & Variation Report - March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board to consider Dividend",
      "datetime": "28-May-2026",
      "details": "The Board of Directors of the comoany at the meeting held on Wednesday May 27 2026 recommnded payment of Final Dividend of Rs. 1.00 per Equity Share of the face value of Rs. 10.00 each for the financial year ended March 31 2026 subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medicamen Biotech Ltd Valuation Shifts Amidst Sector Challenges

2026-05-11 08:01:36

Medicamen Biotech Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting changing market perceptions and relative peer positioning. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the company’s valuation metrics reveal a complex picture of price attractiveness amid sector volatility and competitive pressures.

Medicamen Biotech Ltd is Rated Strong Sell

2026-05-05 10:10:17

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-24 10:10:31

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Medicamen Biotech Ltd Valuation Shifts Signal Changing Market Sentiment

2026-04-23 08:00:58

Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite a recent uptick in its share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside subdued returns on capital, have raised concerns among investors and analysts alike.

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-13 10:10:32

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 13 April 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects.

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-02 10:10:29

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook.

View All News